CLINICAL_TRIALS
trial_result
· 2023-01-17
Clinical Trial Update: Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia. [Phase 2]
Summary
Phase 2 trial update on the efficacy and safety of Jaktinib in patients with COVID-19 pneumonia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: COVID-19 Pneumonia | Phase 2 | Status: UNKNOWN